Fusen Pharmaceutical Dividends and Buybacks
Dividend criteria checks 0/6
Fusen Pharmaceutical does not currently pay a dividend.
Key information
0%
Dividend yield
2.1%
Buyback Yield
| Total Shareholder Yield | 2.1% |
| Future Dividend Yield | n/a |
| Dividend Growth | n/a |
| Next dividend pay date | n/a |
| Ex dividend date | n/a |
| Dividend per share | HK$0.0108 |
| Payout ratio | 0% |
Recent dividend and buyback updates
Recent updates
Fusen Pharmaceutical (HKG:1652) Use Of Debt Could Be Considered Risky
May 21
Fusen Pharmaceutical Company Limited's (HKG:1652) Popularity With Investors Under Threat As Stock Sinks 27%
Mar 31Fusen Pharmaceutical (HKG:1652) Use Of Debt Could Be Considered Risky
Dec 14Here's Why Fusen Pharmaceutical (HKG:1652) Can Manage Its Debt Responsibly
Sep 02Fusen Pharmaceutical (HKG:1652) Seems To Use Debt Quite Sensibly
Apr 02A Look At Fusen Pharmaceutical's (HKG:1652) Share Price Returns
Mar 06We Wouldn't Rely On Fusen Pharmaceutical's (HKG:1652) Statutory Earnings As A Guide
Feb 08
Is Fusen Pharmaceutical Company Limited's (HKG:1652) Recent Price Movement Underpinned By Its Weak Fundamentals?
Jan 18Does Fusen Pharmaceutical (HKG:1652) Have A Healthy Balance Sheet?
Dec 28What You Need To Know About Fusen Pharmaceutical Company Limited's (HKG:1652) Investor Composition
Dec 07If You Had Bought Fusen Pharmaceutical (HKG:1652) Shares A Year Ago You'd Have Earned 34% Returns
Nov 20Stability and Growth of Payments
Fetching dividends data
Stable Dividend: Insufficient data to determine if 1652's dividends per share have been stable in the past.
Growing Dividend: Insufficient data to determine if 1652's dividend payments have been increasing.
Dividend Yield vs Market
| Fusen Pharmaceutical Dividend Yield vs Market |
|---|
| Segment | Dividend Yield |
|---|---|
| Company (1652) | 0% |
| Market Bottom 25% (HK) | 3.3% |
| Market Top 25% (HK) | 8.1% |
| Industry Average (Pharmaceuticals) | 3.7% |
| Analyst forecast (1652) (up to 3 years) | n/a |
Notable Dividend: Unable to evaluate 1652's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.
High Dividend: Unable to evaluate 1652's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.
Earnings Payout to Shareholders
Earnings Coverage: 1652 is not paying a notable dividend for the Hong Kong market.
Cash Payout to Shareholders
Cash Flow Coverage: Unable to calculate sustainability of dividends as 1652 has not reported any payouts.